Trial Profile
Clinical Trials Insight: 700035451
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2008
Price :
$35
*
At a glance
- Drugs STF 62247 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 18 Jul 2008 New trial record.